Phase II Study of Low-Dose RAD001(Everolimus) Plus Cisplatin and HDFL (Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) Chemotherapy for First-Line Treatment of Unresectable, Recurrent or Metastatic Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Cisplatin (Primary) ; Everolimus (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Nov 2012 Planned end date changed from 1 Mar 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned End Date changed from 1 Mar 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.